Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....
APHRANEL Global Launch Meeting: Code Breaker, World Maker SHANGHAI, April 9, 2025 /PRNewswire/ -- On May 8, 2025——The APHRANEL Global Launch Meeting will...
NEW YORK, April 9, 2025 /PRNewswire/ -- viaim, an AI hardware company specializing in smart office solutions, is preparing for the official North American launch...
Hg increases its stake in enterprise software provider IFS and becomes co-control shareholder alongside EQT, while existing minority shareholder TA Associates...